Quality of life and outcomes in biliary tract cancer
Part of Cancer, Digestive system clinical trials.
This study tracks how patients with biliary tract cancer feel and do over time in everyday care, using blood tests and surveys. It aims to understand how symptoms and quality of life relate to the disease and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cancer of the bile ducts or gallbladder (biliary tract cancer).
- You are planning to start treatment—either to cure the cancer, prevent it from coming back, or to help with symptoms.
- You are 18 years or older.
- You are willing and able to give permission (consent) to participate.
- You have not had another cancer (except certain skin cancers or early cervical cancer) in the last 5 years.
- You have no medical reason that prevents you from having blood drawn.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for new ways to measure cancer-related “biomarkers” (signals in blood or tumor samples) in people with bile duct cancer or gallbladder cancer. The goal is to improve how these cancers are identified and tracked, which could help doctors make better treatment decisions.
This study analyzes tumor tissue samples from patients with biliary tract cancer (a rare cancer of the bile ducts or gallbladder) to identify genetic and protein markers that may help doctors better understand and treat the disease. Your stored tissue sample and medical records would be used to find patterns that could improve future treatment options.
This trial uses a simple blood test to track how well bile duct cancer responds to treatment and to predict outcomes. It may help doctors make better decisions about surgery and other therapies.
This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.
This study is testing a new blood test that looks for signs of DNA changes linked to biliary tract cancer. It aims to see if the test can find these cancers early. If you have biliary tract cancer or a high suspicion of it, you may be able to help.
This study tracks how bile duct and liver cancers change during treatment, to help doctors find the best therapies for patients. It is for people who are newly diagnosed or starting a new treatment.
Hear when a new Biliary Tract Cancer (CCA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.